Results from a phase 1b multiple ascending-dose study of PRX002/RG7935, an Anti-alpha-synuclein monoclonal antibody, in patients with Parkinson’s disease
暂无分享，去创建一个
J. Jankovic | D. Jennings | J. Quinn | M. Grundman | I. Goodman | D. Schenk | S. Ostrowitzki | M. Martin-Facklam | J. Soto | F. Boess | M. Koller | S. Griffith | D. Ness | G. Kinney | A. Ellenbogen | O. Omidvar | B. Safirstein | S. Issacson